Tedeschi, Alessandra
 Distribuzione geografica
Continente #
AS - Asia 839
NA - Nord America 691
EU - Europa 537
SA - Sud America 141
AF - Africa 18
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.233
Nazione #
US - Stati Uniti d'America 658
SG - Singapore 407
IT - Italia 221
CN - Cina 189
BR - Brasile 112
SE - Svezia 92
VN - Vietnam 69
IN - India 53
FR - Francia 48
DE - Germania 44
IE - Irlanda 36
JP - Giappone 30
FI - Finlandia 22
ID - Indonesia 21
GB - Regno Unito 19
CA - Canada 15
AR - Argentina 14
MX - Messico 13
IQ - Iraq 11
RU - Federazione Russa 11
BD - Bangladesh 10
KR - Corea 10
ES - Italia 9
HK - Hong Kong 9
PL - Polonia 7
AT - Austria 5
EC - Ecuador 5
IL - Israele 5
UA - Ucraina 5
ZA - Sudafrica 5
AU - Australia 4
NL - Olanda 4
AL - Albania 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EG - Egitto 3
PK - Pakistan 3
SA - Arabia Saudita 3
VE - Venezuela 3
BO - Bolivia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.233
Città #
Singapore 255
Ashburn 92
San Jose 80
Florence 73
Beijing 51
New York 51
Chandler 50
Hyderabad 39
Dublin 33
Hefei 33
Tokyo 29
Milan 25
Lauterbourg 23
Rome 23
Los Angeles 22
Ho Chi Minh City 20
Jakarta 20
Dallas 18
Hanoi 17
Chicago 15
Frankfurt am Main 15
São Paulo 15
Council Bluffs 11
Kent 10
Seoul 10
Princeton 9
Helsinki 8
Hong Kong 8
Lappeenranta 8
Wilmington 8
San Mateo 7
The Dalles 7
Washington 7
Atlanta 6
Boston 6
London 6
Munich 6
Nuremberg 6
Phoenix 6
Turku 6
Dearborn 5
Denver 5
Moscow 5
Naples 5
Paris 5
Acerra 4
Baghdad 4
Benalla 4
Brooklyn 4
Da Nang 4
Düsseldorf 4
Haiphong 4
Montreal 4
Orem 4
Pellezzano 4
Rio de Janeiro 4
Santa Clara 4
Seattle 4
St Louis 4
Amsterdam 3
Asti 3
Brescia 3
Cairo 3
Elk Grove Village 3
Johannesburg 3
Norwalk 3
Padua 3
Pune 3
Querétaro 3
Sesto Fiorentino 3
Toronto 3
Vancouver 3
Verona 3
Agawam 2
Amman 2
Bagheria 2
Bari 2
Basra 2
Belo Horizonte 2
Berzo Inferiore 2
Biên Hòa 2
Bremen 2
Bruino 2
Brusciano 2
Buffalo 2
Cattolica 2
Chennai 2
Dicomano 2
Erbil 2
Fairfield 2
Garden City 2
Gdansk 2
Guarulhos 2
Houston 2
Hải Dương 2
Juiz de Fora 2
Kingston 2
Kunming 2
Londrina 2
Manchester 2
Totale 1.311
Nome #
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 151
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 125
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia 118
Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion 117
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 116
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial 115
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 113
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 111
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 107
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 102
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group 100
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 88
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 86
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 85
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 81
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 80
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 79
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 78
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 77
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement 73
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement 71
I complessi sacri e i culti di Praeneste tra l'età arcaica e l'età tardo repubblicana 70
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 48
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort 46
Takotsubo syndrome after BNT162b2 mRNA Covid-19 vaccine: Emotional or causative relationship with vaccination? 32
Totale 2.269
Categoria #
all - tutte 9.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/2022103 1 0 17 17 11 3 4 9 5 5 25 6
2022/2023194 30 23 14 11 11 22 3 12 24 8 32 4
2023/2024344 16 55 36 57 20 80 17 4 1 7 12 39
2024/2025444 8 4 37 8 52 22 10 16 31 73 115 68
2025/20261.135 170 27 71 159 221 74 185 73 72 75 8 0
Totale 2.269